This annual oncology conference, 2023 Summit on Cancer Health Disparities: Reframing and addressing barriers to adoption of precision oncology, will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health disparities and ways to overcome the impact of these factors to optimize outcomes of cancer patients.
SCHD23 is an accredited continuing education activity (CME activity) that will foster collaborative interdisciplinary interactions and partnerships to stimulate the development of new research and clinical practices that reduce cancer health disparities and improve outcomes of the diverse patient population.
TARGET AUDIENCE
- Oncologist and Hematologists
- Oncology and Hematology Nurse Practitioners
- Oncology and Hematology Physician Assistants
- Oncology and Hematology Nurses
- Oncology and Hematology Pharmacists
- Oncology and Hematology Fellows/Residents
- Oncology and Hematology Researchers
- Others interested in cancer disparities
LEARNING OBJECTIVES
Upon successful completion of this educational activity, participants will be able to:
- Identify drivers of cancer health disparities and review their impact on patients along the cancer continuum.
- State the financial and physical barriers and review strategies to navigate these factors to optimize the management of patients with cancer.
- Incorporate evidence-based strategies to minimize the impact of specific drivers of inequity in the management of patients with cancer.
- Review barriers to using precision-guided cancer care and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.
- Describe challenges and develop novel approaches to improve the participation of underrepresented communities in clinical trials.
VENUE:
Grand Hyatt Seattle